Highlands Oncology is a clinical research site located in Fayetteville, Arkansas, United States 72703.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Highlands Oncology has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Metastatic Colorectal Cancer.
Sponsors: Pfizer, Daiichi Sankyo.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology has 6 clinical trials on record, with 3 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Metastatic Colorectal Cancer.
Highlands Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.